Background: Few studies have explored risk stratification of arrhythmic events in patients with ischemic heart diseases according to T-wave alternans (TWA) using modified moving average (MMA) method and heart rate turbulence (HRT). Methods and Results: A retrospective analysis of 63 patients who underwent MMA-based TWA and HRT divided the patients into 3 groups: group-C of 21 controls, group-O of 21 patients with old myocardial infarction (OMI) showing no episodes of sustained ventricular tachyarrhythmia (SVT), and group-V of 21 OMI patients with episodes of SVT who received an implantable cardioverter-defibrillator. Among the 3 groups, positive TWA (≥65 μV) and impaired HRT were observed most frequently in group-V (P<0.05). Using a logistic regression model, TWA yielded an odds ratio of 4.9 (95% confidence interval: 1.2-19.6, P<0.05), which was the only significant covariate for the incidence of life-threatening ventricular arrhythmias during a mean follow-up of 72 months. Conclusions: Patients with OMI showing episodes of SVT have a high risk for cardiac death because of abnormal repolarization and autonomic regulation. The analysis of MMA-based TWA and HRT can be a useful tool for predicting OMI patients at high risk of arrhythmic events. (Circ J 2009; 73: 2223 -2228 
-wave alternans (TWA) and heart rate turbulence (HRT) are claimed to be useful tools for predicting the risk of sudden cardiac death (SCD). Microvolt TWA induced by exercise testing or pacing, or on the defibrillator electrogram, identifies patients at increased risk of arrhythmia events or SCD. TWA represents increased disparity of repolarization in the ventricle on a beat-to-beat basis and may provide a substrate for reentry. [1] [2] [3] [4] [5] [6] [7] [8] TWA has recently been included as a Class 1 recommendation in guidelines for stratifying risk for ventricular arrhythmias. 9 Spectral analyses of traditional TWA, however, require specific equipment with monitored protocols of HR 4 and therefore the clinical application and utility are somewhat limited. Recently, the introduction of a time domain-based method of TWA, termed the "modified moving average" (MMA) analysis, has expanded the application and utility of TWA to ambulatory ECG. [9] [10] [11] [12] HRT is a measure of the autonomic response to perturbations of arterial blood pressure (BP) after a single premature ventricular contraction (PVC). HRT correlates significantly with baroreflex sensitivity and consists of a short initial acceleration followed by deceleration of the HR. HRT is a simple measure for analyzing Holter records.
Two phases of HRT, the early sinus rate acceleration and the late deceleration, are quantified by 2 parameters, termed "turbulence onset" (TO) and "turbulence slope" (TS). The HRT evaluation has been found to be appropriate in risk stratification after myocardial infarction (MI) and for risk prediction. 13, 14 The aim of this study was to evaluate risk stratification of arrhythmic events in patients with old MI (OMI) using MMA-based TWA and HRT.
Methods

Study Subjects
We performed a retrospective analysis of 63 consecutive patients who underwent 24-h Holter monitoring during the period January 2003 to December 2004 at Yokohama Minami Kyosai Hospital. We divided the patients into 3 groups: group-C of 21 control patients without organic heart disease, group-O of 21 patients with OMI but no episodes of sustained ventricular tachyarrhythmia (SVT) and group-V of 21 OMI patients with episodes of SVT who received an implantable cardioverter-defibrillator (ICD). Group-C included patients with palpitations who underwent Holter ECG examination but were proven negative for ventricular tachyarrhythmias or organic heart disease by various noninvasive tests. Patients with OMI had a history of chest pain, serum enzyme elevation and ECG findings compatible with acute or recent MI. All the subjects were confirmed to have coronary occlusive lesions on coronary angiography. Holter ECG recordings were performed 1-3 months after the MI. Left ventricular ejection fraction (LVEF) was assessed by echocardiography in the first week after MI. Patients were eligible for the study if they were in sinus rhythm at the time of the evaluation. Because paroxysmal atrial fibrillation may influence long-term mortality or morbidity, especially in patients with a MI, 15 those with proven episodes were excluded from the study.
Various risk factors and their modifiers included a past history of smoking, hypertension, diabetes mellitus, dyslipidemia, and medications such as angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), β-blockers and/or amiodarone. Hypertension was defined as systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg. Diabetes mellitus was defined as a morning fasting glucose ≥126 mg/dl, hemoglobin A1c ≥6.5%, or use of medication. Dyslipidemia was defined as a low-density lipoprotein-cholesterol level ≥140 mg/dl, high-density lipoprotein-cholesterol level <40 mg/dl or triglycerides ≥150 mg/dl. The study protocol was approved by the Ethics Committee of Yokohama Minami Kyosai Hospital. Written informed consent was given by all patients before enrollment in the study.
After Holter recording, all patients were followed up at the outpatient clinic every 1-2 months to check their clinical status and outcome, and the mean follow-up period was 72±16 months.
TWA
TWA was analyzed from 2 channel records (V1; NASA, V5; CM5) in the ambulatory Holter monitoring, measured at maximum heart rates <120 beats/min. The MARS PC software identified periods of possible TWA using the MMA algorithm, a time domain-based method that bifurcates the beat stream and generates separate moving average templates for odd vs even beats (ABABAB). 10 Average values were updated by a weighting factor of 1/8 of the difference between the ongoing average and the current pair of beats. TWA magnitude was analyzed as a continuous variable and determined for each 15 s of data. Additional algorithms minimized the effect of noise and artifact, and noise level of 20 μV was adopted in system configuration. Further, manual editing was performed if the data were not eligible because of noise or artifacts. The max TWA value was defined as the highest TWA value in either channel. In this study, TWA ≥65 μV was considered positive, according to previous reports. 12, 16 HRT HRT can be quantified by 2numerical parameters, namely TO and TS. TO is the percentage difference between R-R intervals of sinus beats immediately following PVC and those immediately preceding PVC. TO is calculated by the following equation:
where RR-2 and RR-1 represent R-R intervals of sinus beats preceding PVC, and RR1 and RR2 are R-R intervals of sinus beats following PVC. 14 First, TO was measured for every PVC, and then an average value from all the measurements was calculated. Positive values for TO indicated deceleration of sinus rhythm, and negative values indicated acceleration.
TS was defined as the maximum positive regression slope assessed over R-R intervals of any 5 consecutive sinus beats within the first 15 beats after PVC. We defined TO <0% or TS >2.5 ms/R-R interval as normal. HRT was defined by TO, TS, and a combination of both; namely, HRT category 0 indicated both TO and TS as normal values, HRT category 1 was either TO or TS as abnormal, and HRT category 2 was both TO and TS as abnormal values. 17 If HRT could not be calculated because there were none or few suitable PVCs in the records, patients were classified as HRT category 0.
Measured Parameters and Endpoints
We compared the following parameters among the 3 groups: clinical characteristics, past medical history, baseline concomitant medication use, pulse rate, BP, laboratory data, and echocardiographic findings. Sites of infarction and revascularization procedures were compared in group-O and group-V. The outcomes were assessed by the presence and incidence of life-threatening ventricular arrhythmias (ventricular fibrillation, resuscitated cardiac arrest, and sustained ventricular tachycardia either symptomatic or revealed on the internal records of the ICD), SCD or cardiac death. The primary endpoints of the study were defined as the development of life-threatening ventricular arrhythmias, SCD or cardiac death.
Data Analysis
Analyses of MMA-based TWA and HRT were performed using the MARS PC system (GE Healthcare Inc, Milwaukee, WI, USA) with a running software version 7.03. SPSS version 10.0 (SPSS Inc, Chicago, IL, USA) was used for the statistical analysis. Potential risk factors were assessed for their association with the incidence of lifethreatening ventricular arrhythmias or death. Data are expressed as means ± SD for continuous variables. Continuous variables of baseline data were examined by Student's t-test, and the comparisons between before and after treatment were analyzed by a paired t-test.
Fishers exact test was used for categorical variables. Multiple comparisons of continuous variables were performed by analysis of variance, coupled with Scheffe's test. The endpoints were analyzed on an intention-to-treat basis. To evaluate the effect of high levels of TWA and HRT on the risk for death or life-threatening ventricular arrhythmias, we used standard methods for analysis of case-control data and used logistic regression models to estimate the odds ratio (OR) as a measure of relative risk. We present the results from univariate and multivariate models that controlled for age, sex, LVEF, past history of smoking, hypertension, diabetes mellitus, dyslipidemia, taking ACEI or ARB, β-blockers and amiodarone. A P value <0.05 was considered significant.
Results
Baseline Characteristics
There were no significant differences among the 3 groups in past medical history, baseline concomitant medication use, pulse rate, BP and laboratory data ( Table 1) . Of the echocardiographic findings, LVEF was higher and the left ventricular diastolic dimension was lower in group-C than in group-O or -V. There were no differences between group-O and group-V in the sites of infarction or the coronary revascularization procedure.
Positive Results of TWA and HRT Group-V had the highest association of positive results for both TWA and HRT. The value of TWA was the highest in group-V and the lowest in group-C (Table 2, Figure 1 ). HRT category 0 had the highest incidence in group-C, and HRT category 2 was the highest in group-V (Figure 2 ).
Endpoint Results During the Follow-up Period
Six patients died (1 in group-O, 5 in group-V) during a mean follow-up period of 72±52 months. Cardiac death because of heart failure occurred in 1 patient in group-O and 4 in group-V. One patient in group-V died suddenly. Total mortality was significantly high in group-V compared with groups O and C. SVT occurred in 10 cases, with the highest incidence in group-V and 6 patients in group-O ( Table 3) . Group-C had no cases of SVT or death during the follow-up period. There were significant differences between groups C and O in the total mortality and incidence of SVT. Using logistic regression models, TO yielded an OR of 10.8 (95% confidence interval (CI) 1.2-99.6, P<0.05) and TS yielded an OR of 7.9 (95%CI 0.9-72.7, P<0.05), which was the significant covariate for the incidence of death, and furthermore, TWA yielded an OR of 4.9 (95%CI 1.2-19.6, P< 0.05), which was the only significant covariate for the incidence of life-threatening ventricular arrhythmias during the follow-up period (Table 4, Figure 3) . The other parameters were not associated with an increased risk of mortality or life-threatening ventricular arrhythmias (Figure 3) .
Discussion
Recent guidelines for risk stratification of SCD have recommended noninvasive electrophysiological techniques as useful tools for predicting life-threatening arrhythmic events and these techniques include TWA, signal-averaged ECG, HR variability, baroreflex sensitivity and HRT, as well as invasive electrophysiological studies. 18, 19 Because MMAbased TWA and HRT can be simultaneously analyzed from the 24-h ambulatory ECG records, we evaluated the utility of these 2 analyses for predicting arrhythmic events in patients with an OMI and the results demonstrated that MMA-based TWA and HRT were useful for predicting patients at high risk of arrhythmic events.
MMA-Based TWA
The relative risk of mortality for patients with a positive TWA was reported as an OR of 3.8 (95%CI 2.4-5.9) in a meta-analysis of 19 previous studies in which TWA was analyzed by the conventional method of exercise testing. 20 The present study had comparable result using conventional TWA in terms of relative risk prediction for arrhythmic events in patients with OMI. MMA is a time domain method 21 that is suitable for patients who cannot perform an exercise test or are ineligible for pacing because TWA can be analyzed from the ambulatory ECG records. Values obtained from MMAbased TWA using an update factor of 1/8 more closely correlate with the spectral method when an update factor of 1/32 is used. Given the dynamic changes in TWA, an Figure 2 . Distribution of heart rate turbulence (HRT) category in the 3 groups. HRT category 0 occurred most frequently in group-C, and HRT category 2 occurred most frequently in group-V. Multiple comparisons of continuous variables were performed by analysis of variance, coupled with Scheffe's test. Tables 1-3. update factor of 1/8 will typically yield larger TWA values than an update factor of 1/32 or 1/64. One issue related to clinical TWA studies using MMA analysis is that a consensus agreement has not reached for the criteria for abnormal values. Although the pre-specified 46-47 μV cut-off point has been shown to predict a high risk for SCD, patients with TWA values >47 μV were more likely to suffer from serious ventricular arrhythmias during long-term follow-up than those with the lower values by a factor of 2.9-5.5. 11, 20 Nieminen et al reported that a cut-off point of 65 μV could optimally separate patients into a high-risk group of cases referred for routine clinical exercise testing and who later died suddenly or survived aborted sudden death during a follow-up for 4 years. 16 Sakaki et al demonstrated that time-domain TWA with a cut-off point of 65 μV could predict cardiac mortality in patients with left ventricular dysfunction of ischemic and non-ischemic etiologies. 12 Although cut-off values for MMA-based TWA could give significantly higher values than those obtained by the spectral methods, the predictive accuracy of TWA might change according to the study population. 18 Various studies have examined the influence of basal autonomic activity on TWA. Although those studies indicated that using β-blockers and amiodarone decreases the magnitude of TWA, as well as the parameters of HRT, [22] [23] [24] [25] [26] their use did not interfere with the ability of TWA to assess the risk for arrhythmic events. 21 Similarly, this finding may also be confirmed in our study.
Table 3. Incidence of Endpoints During the Study
Event Group-C Group-O Group-V P value (n=21) (n=21)(n=21)
HRT
Several studies have demonstrated that impaired HRT is the strongest ECG risk predictor for life-threatening arrhythmias. 13, 21, 27, 28 Patients with HRT category 2 had a 4.4-to 11.3-fold risk of subsequent death within 2 years compared with those with a normal HRT of category 0. The risk of subsequent death associated with HRT category 2 was as high as in patients with left ventricular dysfunction. 14 In the present study, HRT category 2 was noted most frequently in group-V, which comprised patients with OMI and ICD implantation because of documented SVT, whereas group-C had no cases of HRT category 2 and category 0 predominated. In fact, group-V had a high risk for death and life-threatening arrhythmia events during the follow-up period, so the present study results also support the notion that HRT analysis is useful for predicting the risk for life-threatening arrhythmic events in patients with OMI.
Study Limitations
This was a single-arm retrospective study and the number of participants was small, with a low incidence of serious cardiac and arrhythmic events. Prediction of SCD requires an approach using multi-parameters and a prospective large-scale survey. A large-scale, prospective survey combining MMA-based TWA and HRT with other non-invasive markers is mandatory to confirm the predictive accuracy of these methods for life-threatening arrhythmic events.
Conclusion
The present results indicate that patients with an OMI, especially those complicated with episodes of SVT, have a high risk of life-threatening ventricular arrhythmias possibly because of increased repolarization disparity and abnormal baroreflex sensitivity. Combined analysis using MMAbased TWA and HRT may be an easy and useful method of predicting patients at high risk for such arrhythmic events.
